We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.59B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.97%
2 Technology 1.2%
3 Healthcare 1.19%
4 Consumer Discretionary 0.7%
5 Communication Services 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
226
Enbridge
ENB
$109B
$22K 0.01%
606
GLW icon
227
Corning
GLW
$133B
$22K 0.01%
811
SNAP icon
228
Snap
SNAP
$9.25B
$22K 0.01%
1,647
EXC icon
229
Exelon
EXC
$45B
$21K 0.01%
701
-2,503
-78% -$71.7K
HUM icon
230
Humana
HUM
$48.2B
$21K 0.01%
71
-5
-7% -$1.46K
IYY icon
231
iShares Dow Jones US ETF
IYY
$3.06B
$21K 0.01%
310
+60
+24% +$4.07K
NTAP icon
232
NetApp
NTAP
$36.5B
$21K 0.01%
270
RWR icon
233
State Street SPDR Dow Jones REIT ETF
RWR
$1.84B
$21K 0.01%
221
SBUX icon
234
Starbucks
SBUX
$119B
$21K 0.01%
430
SPHB icon
235
Invesco S&P 500 High Beta ETF
SPHB
$914M
$21K 0.01%
496
+4
+0.8% +$174
TXN icon
236
Texas Instruments
TXN
$236B
$21K 0.01%
186
-48
-21% -$5.19K
USIG icon
237
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.7B
$21K 0.01%
400
APC
238
DELISTED
Anadarko Petroleum
APC
$21K 0.01%
288
TFCF
239
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$21K 0.01%
432
BMRN icon
240
BioMarin Pharmaceuticals
BMRN
$12.9B
$20K 0.01%
210
BMY icon
241
Bristol-Myers Squibb
BMY
$136B
$20K 0.01%
363
+50
+16% +$2.7K
DFE icon
242
WisdomTree Europe SmallCap Dividend Fund
DFE
$172M
$20K 0.01%
300
MDY icon
243
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.5B
$20K 0.01%
55
+11
+25% +$3.87K
MET icon
244
MetLife
MET
$62B
$20K 0.01%
469
SHW icon
245
Sherwin-Williams
SHW
$81B
$20K 0.01%
150
AIG icon
246
American International
AIG
$39.8B
$19K 0.01%
360
+101
+39% +$5.47K
ISCB icon
247
iShares Morningstar Small-Cap ETF
ISCB
$287M
$19K 0.01%
420
PDP icon
248
Invesco Dorsey Wright Momentum ETF
PDP
$1.47B
$19K 0.01%
340
RSPT icon
249
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.85B
$19K 0.01%
1,220
RWK icon
250
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
$19K 0.01%
305

Similar funds

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.